Comparing Brolucizumab vs Vabysmo
| Brolucizumab | Vabysmo (faricimab) |
|
|---|
| Brolucizumab | Vabysmo (faricimab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Brolucizumab is an injectable eye preparation that may be used to treat neovascular (wet) age-related macular degeneration (AMD). After an initial dosing period, it is given once every three months... View more |
Prescription only
Prescribed for Macular Degeneration, Macular Edema, Macular Edema Following Retinal Vein Occlusion, Diabetic Macular Edema. Vabysmo may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
Diabetic Macular Edema
|
|||||||
| More about Brolucizumab | More about Vabysmo (faricimab) | ||||||||
| Ratings & Reviews | |||||||||
|
Brolucizumab has an average rating of 7.0 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Vabysmo has an average rating of 7.7 out of 10 from a total of 33 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Brolucizumab side effects |
View all Vabysmo side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vabysmo prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Beovu |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
105.6 hours |
180 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
October 07, 2019 |
January 28, 2022 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.